We are live on ! Find out more
T. Rowe Price Associates

T. Rowe Price Associates Portfolio holdings

AUM $865B
1-Year Est. Return 30.76%
 

T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.

This Fund
S&P 500
This Quarter Est. Return
-0.3%
1 Year Est. Return
+30.76%
3 Year Est. Return
+117.39%
5 Year Est. Return
+143.85%
10 Year Est. Return
+1,089.89%
AUM
$468B
AUM Growth
-$6.98B
Cap. Flow
+$2.33B
Cap. Flow %
0.5%
Top 10 Hldgs %
16.09%
Holding
2,594
New
78
Increased
1,210
Reduced
770
Closed
91

Top Buys

Rank Stock Value
1
NXPI icon
NXP Semiconductors
NXPI
+$1.36B
2
PM icon
Philip Morris
PM
+$1.3B
3
AMZN icon
Amazon
AMZN
+$1.21B
4
SYK icon
Stryker
SYK
+$1.12B
5
AET
Aetna Inc
AET
+$1.08B

Top Sells

Rank Stock Value
1
BHC icon
Bausch Health
BHC
+$1.46B
2
GILD icon
Gilead Sciences
GILD
+$1.1B
3
DIS icon
Walt Disney
DIS
+$866M
4
AKAM icon
Akamai
AKAM
+$703M
5
CMG icon
Chipotle Mexican Grill
CMG
+$647M

Sector Composition

Rank Sector Weight
1 Healthcare 20.69%
2 Consumer Discretionary 15.01%
3 Financials 13.64%
4 Technology 12.55%
5 Industrials 10.03%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TTPH
2426
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
$78K ﹤0.01%
840
KRO icon
2427
KRONOS Worldwide
KRO
$986M
$77K ﹤0.01%
13,500
HHS icon
2428
Harte-Hanks
HHS
$22.1M
$76K ﹤0.01%
2,985
SOHO
2429
DELISTED
Sotherly Hotels
SOHO
$75K ﹤0.01%
14,600
WVVI icon
2430
Willamette Valley Vineyards
WVVI
$11.5M
$75K ﹤0.01%
10,850
TCS
2431
DELISTED
THE CONTAINER STORE GROUP, INC.
TCS
$75K ﹤0.01%
847
LTS
2432
DELISTED
Ladenburg Thalmann Financial Services Inc
LTS
$74K ﹤0.01%
29,700
III icon
2433
Information Services Group
III
$249M
$73K ﹤0.01%
18,600
UCTT
2434
Ultra Clean Holdings
UCTT
$4.29B
$69K ﹤0.01%
12,800
HTCH
2435
DELISTED
HUTCHINSON TECHNOLOGY INC
HTCH
$69K ﹤0.01%
18,800
TLPH icon
2436
Talphera
TLPH
$62.3M
$68K ﹤0.01%
1,101
-1,816
-62% -$126K
ZIXI
2437
DELISTED
Zix Corporation
ZIXI
$68K ﹤0.01%
17,200
SQNM
2438
DELISTED
SEQUENOM INC NEW
SQNM
$67K ﹤0.01%
47,300
CAW
2439
DELISTED
CCA Industries, Inc.
CAW
$67K ﹤0.01%
19,247
EVRI
2440
DELISTED
Everi Holdings
EVRI
$66K ﹤0.01%
28,900
PCYO icon
2441
Pure Cycle
PCYO
$273M
$66K ﹤0.01%
14,700
AIOT
2442
PowerFleet Inc
AIOT
$420M
$66K ﹤0.01%
15,300
NAVB
2443
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$66K ﹤0.01%
3,520
VOXX
2444
DELISTED
VOXX International Corporation Class A
VOXX
$65K ﹤0.01%
14,464
TRQ
2445
DELISTED
Turquoise Hill Resources Ltd
TRQ
$63K ﹤0.01%
2,470
QMCO icon
2446
Quantum Corp
QMCO
$979M
$61K ﹤0.01%
621
INSG icon
2447
Inseego
INSG
$78.2M
$60K ﹤0.01%
3,390
XOMA
2448
DELISTED
Xoma
XOMA
$60K ﹤0.01%
3,873
ENZ
2449
DELISTED
Enzo Biochem, Inc.
ENZ
$60K ﹤0.01%
13,100
SZYM
2450
DELISTED
SOLAZYME INC COM STK (DE)
SZYM
$57K ﹤0.01%
28,200

Similar funds

T. Rowe Price Associates's Q1 2016 Portfolio in Review

As of Q1 2016, T. Rowe Price Associates held 2,594 positions worth $468B, down 1.5% from $475B the previous quarter. Its ten largest holdings account for 16% of the portfolio.

T. Rowe Price Associates's Q1 2016 filing shows 78 new, 1,210 increased, 770 reduced and 91 closed positions. Its largest new stake was BRF SA: 5,750,603 shares worth $81.8M. The largest sale was Bausch Health, an estimated $1.46B.

By sector, the portfolio is most concentrated in Healthcare at 21% of assets, down from 22% a quarter earlier, followed by Consumer Discretionary and Financials.

  • T. Rowe Price Associates's largest Q1 2016 buy was BRF SA: 5,750,603 shares worth $81.8M.
  • T. Rowe Price Associates added most to NXP Semiconductors in Q1 2016, an estimated $1.36B increase.
  • T. Rowe Price Associates's biggest Q1 2016 reduction was Bausch Health, cutting an estimated $1.46B.
  • T. Rowe Price Associates fully exited CHUBB CORPORATION in Q1 2016, selling an estimated $496M.
  • T. Rowe Price Associates's ten largest holdings make up 16% of its $468B portfolio in Q1 2016.
  • T. Rowe Price Associates opened 78 new positions and closed 91 in Q1 2016.
  • T. Rowe Price Associates's portfolio value fell 1.5% quarter-over-quarter to $468B.

Based on T. Rowe Price Associates's 13F filing for Q1 2016, filed 16 May 2016.